PTC THERAPEUTICS, INC. — Director's Dealing 2019

Jan 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2019-01-07

Reporting Person: Almstead Neil Gregory (Chief Technical Ops Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-07	Common Stock	S	473	$34.75	Disposed	17396	Direct
2019-01-07	Common Stock	S	57	$34.75	Disposed	5772	Indirect
2019-01-07	Common Stock	S	55	$34.75	Disposed	5717	Indirect
2019-01-07	Common Stock	S	68	$34.75	Disposed	5649	Indirect

Footnotes

F1: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,500 shares of restricted stock from a January 3, 2017 grant of 6,000 shares of restricted stock.

F2: Includes 715 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018.

F3: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 187 RSUs from a January 4, 2016 grant of 750 RSUs.

F4: Includes 704 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2018.

F5: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 180 RSUs from a January 3, 2017 grant of 720 RSUs.

F6: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 218 RSUs from a January 3, 2018 grant of 874 RSUs.